Protein τ-mediated effects on rat hippocampal choline transporters CHT1 and τ-amyloid β interactions

Neurochemical Research

Volumn 38, Issue 9, 2013, Pages 1949-1959

  Kristofikova, Zdena ^a   Ripova, Daniela ^a   Hegnerová, Katerina ^b   Sirova, Jana ^a   Homola, Jiri ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b INSTITUTE OF PHOTONICS AND ELECTRONICS   (Czech Republic)

Author keywords

Amyloid peptide; Choline transporter; Interactions; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; ISOPROTEIN; MEMBRANE PROTEIN; PROTEIN CHT1; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANALYSIS OF VARIANCE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BIOSENSOR; CEREBROSPINAL FLUID; CONTROLLED STUDY; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; LIMIT OF DETECTION; MALE; MICHAELIS CONSTANT; MOLECULAR RECOGNITION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SURFACE PLASMON RESONANCE; SYNAPTOSOME;

RATTUS;

AMYLOID BETA-PEPTIDES; ANIMALS; CATION TRANSPORT PROTEINS; HIPPOCAMPUS; MALE; RATS; RATS, WISTAR; SURFACE PLASMON RESONANCE; TAU PROTEINS;

EID: 84881477305     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1101-5     Document Type: Article

References (33)

1. Wirths O, Multhaup G, Bayer TA (2004) A modified β-amyloid hypothesis: intraneuronal accumulation of the β-amyloid peptide - the first step of a fatal cascade. J Neurochem 91:513-520
2. Sadot E, Gurwitz D, Barg J, Behar L, Ginzburg I, Fisher A (1996) Activation of m1 muscarinic acetylcholine receptor regulates tau phosphoryltion in transfected PC12 cells. J Neurochem 66:877-880
3. Pavía J, de Ceballos ML, Sanchez de la Cuesta F (1998) Alzheimer′s disease: relationship between muscarinic cholinergic receptors, β-amyloid and tau protein. Fundam Clin Pharmacol 12:473-481
4. Forlenza OV, Spink JM, Dayanandan R, Anderton BH, Olesen OF, Lovestone S (2000) Muscarinic agonists reduce tau phosphorylation in nin-neuronal cells via GSK-3β inhibition and in neurons. J Neural Transm 107:1201-1212
5. Gómez-Ramos A, Díaz-Hernández M, Cuadros R, Hérnández F, Avila J (2006) Extracellular tau is toxic to neuronal cells. FEBS Lett 580:4842-4850
6. Gómez-Ramos A, Díaz-Hernández M, Rubio A, Mirtas-Portugal MT, Avila J (2008) Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells. Mol Cell Neurosci 37:673-681
7. Gómez-Ramos A, Díaz-Hernández M, Rubio A, Díaz-Hernández JI, Miras-Portugal MT, Avila J (2009) Characteristics and consequences of muscarinic receptor activation by tau protein. Eur Neuropsychopharmacol 19:708-717
8. Díaz-Hernández M, Gómez-Ramos A, Rubio A, Gómez-Villafuertes R, Naranjo JR, Miras-Portugal MT, Avila J (2010) Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau. J Biol Chem 285:32539-32548
9. Magnoni S, Esparza TJ, Conte V, Carbonara M, Carrabba G, Holtzman DM, Zipfel GJ, Stocchetti N, Brody DL (2012) Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury. Brain 135:1268-1280
10. Avila J (2010) Intracellular and extracellular tau. Front Neurosci 4:49. doi: 10.3389/fnins.2010.00049
11. Karch CM, Jeng AT, Goate AM (2012) Extracellular tau levels are influenced by variability in tau that is associated with tauopathies. J Biol Chem 287:42751-42762
12. Butner KA, Kirschner MW (1991) Tau protein binds to microtubules through a flexible array of distributes weak sites. J Cell Biol 115:717-730
13. von Bergen M, Barghorn S, Jeganathan S, Mandelkow EM, Mandelkow E (2006) Spectroscopic approaches to the conformation of tau protein in solution and in paired helical filaments. Neurodegener Dis 3:197-206
14. Horowitz PM, LaPointe N, Guillozet-Bongaarts AL, Berry RW, Binder LI (2006) N-terminal fragments of tau inhibit full-length tau polymerization in vitro. Biochemistry 45:12859-12866
15. Magnani E, Fan J, Gasparini L, Golding M, Williams M, Schiavo G, Goedert M, Amos LA, Spillantini MG (2007) Interaction of tau protein with the dynactin complex. EMBO J 26:4546-4554
16. Rosenberg KJ, Ross JL, Feinstein HE, Feinstein SC, Israelachvili J (2008) Complementary dimerization of microtubule-associated tau protein: implications for microtubule bundling and tau-mediated pathogenesis. Proc Natl Acad Sci USA 105:7445-7450
17. Adams SJ, DeTure MA, McBride M, Dickson DW, Petrucelli L (2010) Three repeat isoforms of tau inhibit assembly of four repeat tau filaments. PLoS ONE 5:e10810
18. Ittner LM, Götz J (2011) Amyloid-β and tau - a toxic pas de deux in Alzhemer′s disease. Nat Rev Neurosci 12:67-72
19. Shipton OA, Leitz JR, Dworzak J, Acton CEJ, Tunbridge EM, Denk F, Dawson HN, Vitek MP, Wade-Martins R, Paulsen O, Vargas-Caballero M (2011) Tau protein is required for amyloid β-induced impairment of hippocampal long-term potentiation. J Neurosci 31:1688-1692
20. Pérez M, Cuadros R, Benítez MJ, Jiménez JS (2004) Interaction of Alzheimer′s disease amyloid β peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain. J Alzheimers Dis 6:461-467
21. Guo JP, Arai T, Miklossy J, McGeer PL (2006) Aβ and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer′s disease. Proc Natl Acad Sci USA 103:1953-1958
22. Arendt T, Holzer M, Gertz HJ, Brückner KM (1999) Cortical load of PHF-tau in Alzheimer′s disease is correlated to cholinergic dysfunction. J Neural Transm 106:513-523
23. Zheng WH, Bastianetto S, Mennicken F, Ma W, Kar S (2002) Amyloid β peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience 115:201-2002
24. Härtig W, Stieler J, Boerema AS, Wolf J, Schmidt U, Weißfuß J, Bullmann T, Strijkstra AM, Arendt T (2007) Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons-implications for Alzheimer′s disease. Eur J Neurosci 25:69-80
25. Kristofikova Z, Tejkalova H, Klaschka J (2001) Amyloid beta peptide 1-40 and the function of rat hippocampal hemicholinium-3 sensitive choline carriers: effects of a proteolytic degradation in vitro. Neurochem Res 26:203-212
26. Kristofikova Z, Ricny J, Kozmikova I, Ripova D, Zach P, Klaschka J (2006) Sex-dependent actions of amyloid beta peptides on hippocampal choline carriers of postnatal rats. Neurochem Res 31:351-360
27. Kristofikova Z, Kriz Z, Ripova D, Koca J (2012) Interactions of amyloid β peptide 1-40 and cerebrosterol. Neurochem Res 37:604-613
28. Homola J, Dostalek J, Chen S, Rasooly A, Jiang S, Yee SS (2002) Spectral surface plasmon resonance biosensor for detection of staphylococcal enterotoxin B in milk. Int J Food Microbiol 75:61-69
29. Kristofikova Z, Bockova M, Hegnerova K, Bartos A, Klaschka J, Ricny J, Ripova D, Homola J (2009) Enhanced levels of mitochondrial enzyme 17β-hydroxysteroid dehydrogenase type 10 in patients with Alzheimer disease and multiple sclerosis. Mol BioSyst 5:1174-1179
30. Ferguson SSG, Rylett RJ, Collier B (1994) Regulation of rat brain synaptosomal [3H]hemicholinium-3 binding and [3H]choline transport sites following exposure to choline mustard aziridinium ion. J Neurochem 63:1328-1337
31. Nie CL, Wei Y, Chen X, Liu YY, Dui W, Liu Y, Davies MC, Tendler SJB, He RG (2007) Formaldehyde at low concentration induces protein tau into globular amyloid-like aggregates in vitro and in vivo. PLoS ONE 2:e629. doi: 10.1371/journal.pone.0000629
32. Kar S, Issa AM, Seto D, Auld DS, Collier B, Quirion R (1998) Amyloid β-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. J Neurochem 70:2179-2187
33. Kristofikova Z, Kopecky V, Hofbauerova K, Hovorkova P, Ripova D (2008) Complex of amyloid β peptides with 24-hydroxycholesterol and its effect on hemicholinium-3 sensitive carriers. Neurochem Res 33:412-421